Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

Autor: M M, Patnaik, E, Padron, R R, LaBorde, T L, Lasho, C M, Finke, C A, Hanson, J M, Hodnefield, R A, Knudson, R P, Ketterling, A, Al-kali, A, Pardanani, N A, Ali, R S, Komrokji, R S, Komroji, A, Tefferi

Publikováno v: Leukemia. 27:1504-1510

We evaluated the prognostic relevance of several clinical and laboratory parameters in 226 Mayo Clinic patients with chronic myelomonocytic leukemia (CMML): 152 (67%) males and median age 71 years. At a median follow-up of 15 months, 166 (73%) deaths

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4565a4bcbdf709656261d1e02d189d3
https://doi.org/10.1038/leu.2013.88

Small molecules modulating RNA splicing: a review of targets and future perspectives.

Autor: Bouton, Léa, Ecoutin, Agathe, Malard, Florian, Campagne, Sébastien

Publikováno v: RSC Medicinal Chemistry; Apr2024, Vol. 15 Issue 4, p1109-1126, 18p

Clinical and Immune Effects of Peri-Transplantation JAK Inhibition for Myelofibrosis.

Autor: Rathje K; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Gagelmann N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Badbaran A; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Langebrake C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Dadkhah A; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Richter J; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Massoud R; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schäfersküpper M; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Marquard FE; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Oechsler S; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Klyuchnikov E; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Rudolph I; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Heidenreich S; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Niederwieser C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Lueck C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Janson D; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Wolschke C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fehse B; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Ayuk F; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Nov 16. Date of Electronic Publication: 2024 Nov 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome Screening.

Autor: De Almeida Braga C; Nantes Université, École Centrale Nantes, Nantes, France., Bauvais M; Hematology Biology, Nantes University Hospital, Nantes, France., Sujobert P; Hematology Biology, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre Bénite, France., Heiblig M; Hematology Clinic, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre Bénite, France., Jullien M; CRCI2NA, INSERM U1307, CNRS, Nantes Université, Nantes, France., Le Calvez B; CRCI2NA, INSERM U1307, CNRS, Nantes Université, Nantes, France., Richard C; Hematology Biology, Nantes University Hospital, Nantes, France., Le Roc'h V; Hematology Biology, Nantes University Hospital, Nantes, France., Rault E; Hematology Biology, Tours University Hospital, Tours, France., Hérault O; Hematology Biology, Tours University Hospital, Tours, France., Peterlin P; Hematology Clinic, Nantes University Hospital, Nantes, France., Garnier A; Hematology Clinic, Nantes University Hospital, Nantes, France., Chevallier P; CRCI2NA, INSERM U1307, CNRS, Nantes Université, Nantes, France.; Hematology Clinic, Nantes University Hospital, Nantes, France., Bouzy S; Hematology Biology, Nantes University Hospital, Nantes, France., Le Bris Y; Hematology Biology, Nantes University Hospital, Nantes, France.; Hematology Biology, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre Bénite, France., Néel A; Internal Medicine, Nantes University Hospital, Nantes, France., Graveleau J; Saint Nazaire General Hospital, Saint Nazaire, France., Kosmider O; Hematology Biology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France., Paul-Gilloteaux P; Nantes Université, CHU Nantes, CNRS, Inserm, BioCore, Nantes, France., Normand N; Nantes Université, École Centrale Nantes, Nantes, France., Eveillard M; Hematology Biology, Nantes University Hospital, Nantes, France.; CRCI2NA, INSERM U1307, CNRS, Nantes Université, Nantes, France.

Publikováno v: International journal of laboratory hematology [Int J Lab Hematol] 2024 Sep 14. Date of Electronic Publication: 2024 Sep 14.